Ahn, Y., Kim, Y., Chang, K., Kim, W., Rhee, M., Cha, K. S., . . . Ahn, T. (2018). A multicenter, randomized, and double-blind phase IV clinical trial to compare the efficacy and safety of fixed-dose combinations of amlodipine orotate/valsartan 5/160 mg versus valsartan/hydrochlorothiazide 160/12.5 mg in patients with essential hypertension uncontrolled by valsartan 160 mg monotherapy. Medicine (Baltimore).
Čikaški stil citiranjaAhn, Youngkeun, et al. "A Multicenter, Randomized, and Double-blind Phase IV Clinical Trial to Compare the Efficacy and Safety of Fixed-dose Combinations of Amlodipine Orotate/valsartan 5/160 mg Versus Valsartan/hydrochlorothiazide 160/12.5 mg in Patients With Essential Hypertension Uncontrolled By Valsartan 160 mg Monotherapy." Medicine (Baltimore) 2018.
MLA način citiranjaAhn, Youngkeun, et al. "A Multicenter, Randomized, and Double-blind Phase IV Clinical Trial to Compare the Efficacy and Safety of Fixed-dose Combinations of Amlodipine Orotate/valsartan 5/160 mg Versus Valsartan/hydrochlorothiazide 160/12.5 mg in Patients With Essential Hypertension Uncontrolled By Valsartan 160 mg Monotherapy." Medicine (Baltimore) 2018.